- +250.4% price growth over the last year
- Beat earnings estimates in 3 of the last 4 quarters
- +76.4% YTD performance
Apogee Therapeutics, Inc. stock price ended at $133.65 on Friday, after gaining 0.0599%
(Updated on Jul 10, 2026)
The Apogee Therapeutics, Inc. stock price gained 0.0599% on the last trading day (Friday, 10th Jul 2026), rising from $133.57 to $133.65. During the last trading day the stock fluctuated 0.285% from a day low at $133.36 to a day high of $133.74. The price has risen in 8 of the last 10 days and is up by 0.73% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 774 thousand shares were bought and sold for approximately $103.49 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $129.36, a level that may pose a second chance to hit a runner. According to fan-theory $160.29 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
APGE Signals & Forecast
The Apogee Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $133.31 and $103.61. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 61.57%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Apogee Therapeutics, Inc. stock
Apogee Therapeutics, Inc. finds support from accumulated volume at $132.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.380 between high and low, or 0.285%. For the last week, the stock has had daily average volatility of 0.316%.
The Apogee Therapeutics, Inc. stock is extremely overbought on RSI14 (99). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stop-loss: $127.61 (-4.52%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 99 and this increases the risk substantially. There is a buy signal from a pivot bottom found 20 days ago.)
Trading Expectations (APGE) For The Upcoming Trading Day Of Monday 13th
For the upcoming trading day on Monday, 13th we expect Apogee Therapeutics, Inc. to open at $133.58, and during the day (based on 14 day Average True Range), to move between $132.11 and $135.19, which gives a possible trading interval of +/-$3.09 (+/-2.34%) up or down from last closing price. If Apogee Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 2.34% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $132.88, some $0.770 (0.58%) from the current price of $133.65, our system finds the risk reward attractive.
Is Apogee Therapeutics, Inc. stock A Buy?
Apogee Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.000
Hold/Accumulate
Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on July 13, 2026 - $133.58 ( 0.0499%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
APGE Performance
Trading levels for APGE
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 133.96 | 0.234% |
| R2 | 133.82 | 0.126% |
| R1 | 133.73 | 0.0587% |
| Price | 133.65 | |
| S1 | 133.44 | -0.158% |
| S2 | 133.35 | -0.226% |
| S3 | 133.20 | -0.334% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 133.65 | |
| S1 | 132.88 | -0.576% |
| S2 | 132.69 | -0.718% |
| S3 | 132.55 | -0.82% |
FAQ
Click here for our free guide on how to buy Apogee Therapeutics, Inc. Stock.
Buy APGE